356 related articles for article (PubMed ID: 19793612)
21. Immunophenotypic profile of acute leukemia: critical analysis and insights gained at a tertiary care center in India.
Gujral S; Badrinath Y; Kumar A; Subramanian PG; Raje G; Jain H; Pais A; Amre Kadam PS; Banavali SD; Arora B; Kumar P; Hari Menon VG; Kurkure PA; Parikh PM; Mahadik S; Chogule AB; Shinde SC; Nair CN
Cytometry B Clin Cytom; 2009 May; 76(3):199-205. PubMed ID: 18803279
[TBL] [Abstract][Full Text] [Related]
22. Dendritic cell recovery after allogeneic stem-cell transplantation in acute leukemia: correlations with clinical and transplant characteristics.
Porta MD; Rigolin GM; Alessandrino EP; Maiocchi M; Malcovati L; Vanelli L; Baratè C; Rumi E; Ciccone M; Cuneo A; Lazzarino M; Castoldi G
Eur J Haematol; 2004 Jan; 72(1):18-25. PubMed ID: 14962258
[TBL] [Abstract][Full Text] [Related]
23. CD4+CD56+ hematodermic neoplasms bear a plasmacytoid dendritic cell phenotype.
Urosevic M; Conrad C; Kamarashev J; Asagoe K; Cozzio A; Burg G; Dummer R
Hum Pathol; 2005 Sep; 36(9):1020-4. PubMed ID: 16153467
[TBL] [Abstract][Full Text] [Related]
24. A blastic plasmacytoid dendritic cell neoplasm-like immunophenotype is negatively associated with CEBPA bZIP mutation and predicts unfavorable prognosis in acute myeloid leukemia.
Song J; Li W; Bai Y; Zhou P; Niu J; Niu X; Liu Y; Liu X; Drokow EK; Sun K; Zhou H
Ann Hematol; 2024 Feb; 103(2):463-473. PubMed ID: 38183444
[TBL] [Abstract][Full Text] [Related]
25. Plasmacytoid dendritic cell leukemia with potent antigen-presenting ability.
Narita M; Kuroha T; Watanabe N; Hashimoto S; Tsuchiyama J; Tochiki N; Saitoh A; Satoh N; Furukawa T; Toba K; Fuse I; Aizawa Y; Takahashi M
Acta Haematol; 2008; 120(2):91-9. PubMed ID: 18948686
[TBL] [Abstract][Full Text] [Related]
26. [Immunophenotyping of acute leukemias: diagnostic and pronostic utility in Abidjan, Côte d'Ivoire].
Inwoley KA; Sawadogo D; Mizero L; Salou M; Karim N; Sangaré A
Bull Soc Pathol Exot; 2004; 97(5):319-22. PubMed ID: 15787262
[TBL] [Abstract][Full Text] [Related]
27. CD56(+) TdT(+) blastic natural killer cell tumor of the skin: a primitive systemic malignancy related to myelomonocytic leukemia.
Khoury JD; Medeiros LJ; Manning JT; Sulak LE; Bueso-Ramos C; Jones D
Cancer; 2002 May; 94(9):2401-8. PubMed ID: 12015765
[TBL] [Abstract][Full Text] [Related]
28. Flow cytometric determination of atypical antigen expression in acute leukemia for the study of minimal residual disease.
Drach J; Drach D; Glassl H; Gattringer C; Huber H
Cytometry; 1992; 13(8):893-901. PubMed ID: 1459006
[TBL] [Abstract][Full Text] [Related]
29. Blastic plasmacytoid dendritic cell neoplasm: a single-center experience.
An HJ; Yoon DH; Kim S; Shin SJ; Huh J; Lee KH; Suh C
Ann Hematol; 2013 Mar; 92(3):351-6. PubMed ID: 23135479
[TBL] [Abstract][Full Text] [Related]
30. [Correlation of immunophenotype to cytogenetics and clinical features of adult acute myeloid leukemia].
Wang XB; Zheng JE; Gu JX; Yao JX; Yang J; Liu J; Li XQ; He YL; Yu JM; Wei J; Liu ZP; Huang SA
Ai Zheng; 2005 Jun; 24(6):667-71. PubMed ID: 15946475
[TBL] [Abstract][Full Text] [Related]
31. Blastic plasmacytoid dendritic cell neoplasm: a clinicopathologic review.
Shi Y; Wang E
Arch Pathol Lab Med; 2014 Apr; 138(4):564-9. PubMed ID: 24678689
[TBL] [Abstract][Full Text] [Related]
32. [Rare diagnosis of CD4+56+ leukemia from dendritic cells type DC2].
Klabusay M; Pevná M; Kissová J; Doubek M; Heidekerová M; Mayer J; Vorlícek J
Cas Lek Cesk; 2008; 147(10):511-5. PubMed ID: 19177732
[TBL] [Abstract][Full Text] [Related]
33. Myeloid Cell Nuclear Differentiation Antigen (MNDA) Expression Distinguishes Extramedullary Presentations of Myeloid Leukemia From Blastic Plasmacytoid Dendritic Cell Neoplasm.
Johnson RC; Kim J; Natkunam Y; Sundram U; Freud AG; Gammon B; Cascio MJ
Am J Surg Pathol; 2016 Apr; 40(4):502-9. PubMed ID: 26796502
[TBL] [Abstract][Full Text] [Related]
34. Specific skin lesions in chronic myelomonocytic leukemia: a spectrum of myelomonocytic and dendritic cell proliferations: a study of 42 cases.
Vitte F; Fabiani B; Bénet C; Dalac S; Balme B; Delattre C; Vergier B; Beylot-Barry M; Vignon-Pennamen D; Ortonne N; Algros MP; Carlotti A; Samaleire D; Frouin E; Levy A; Laroche L; Theate I; Monnien F; Mugneret F; Petrella T
Am J Surg Pathol; 2012 Sep; 36(9):1302-16. PubMed ID: 22895265
[TBL] [Abstract][Full Text] [Related]
35. Prognostic value of immunophenotyping in elderly patients with acute myeloid leukemia: a single-institution experience.
Plesa C; Chelghoum Y; Plesa A; Elhamri M; Tigaud I; Michallet M; Dumontet C; Thomas X
Cancer; 2008 Feb; 112(3):572-80. PubMed ID: 18085638
[TBL] [Abstract][Full Text] [Related]
36. Leukemias of indeterminant lineage.
Lee EJ; Schiffer CA
Clin Lab Med; 1990 Dec; 10(4):737-54. PubMed ID: 2272172
[TBL] [Abstract][Full Text] [Related]
37. The CD4+ CD56+ CD116- CD123+ CD45RA+ CD45RO- profile is specific of DC2 malignancies.
Trimoreau F; Donnard M; Turlure P; Gachard N; Bordessoule D; Feuillard J
Haematologica; 2003 Mar; 88(3):ELT10. PubMed ID: 12651292
[No Abstract] [Full Text] [Related]
38. CD4+ CD56+ blastic tumor of the skin: cytogenetic observations and further evidence of an origin from plasmocytoid dendritic cells.
Hallermann C; Middel P; Griesinger F; Gunawan B; Bertsch HP; Neumann C
Eur J Dermatol; 2004; 14(5):317-22. PubMed ID: 15358570
[TBL] [Abstract][Full Text] [Related]
39. Flow Cytometry Identifies a Spectrum of Maturation in Myeloid Neoplasms Having Plasmacytoid Dendritic Cell Differentiation.
Hamadeh F; Awadallah A; Meyerson HJ; Beck RC
Cytometry B Clin Cytom; 2020 Jan; 98(1):43-51. PubMed ID: 30614203
[TBL] [Abstract][Full Text] [Related]
40. Blastic plasmacytoid dendritic cell neoplasm expressing the CD13 myeloid antigen.
Inoue D; Maruyama K; Aoki K; Nagano S; Maruoka H; Imai Y; Ito K; Ishikawa T; Takahashi T
Acta Haematol; 2011; 126(2):122-8. PubMed ID: 21701157
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
